These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 9582586

  • 1. Urinary pharmacodynamics of low-dose ciprofloxacin and ofloxacin.
    Stein GE, Schooley S, McMillan J.
    Diagn Microbiol Infect Dis; 1998 Apr; 30(4):261-5. PubMed ID: 9582586
    [Abstract] [Full Text] [Related]

  • 2. [Antibacterial activity of ofloxacin in urine for 4 days after a single oral dose of 400 mg].
    Guibert J, Kitzis MD, Acar JF.
    Pathol Biol (Paris); 1998 Oct; 46(8):656-60. PubMed ID: 9871938
    [Abstract] [Full Text] [Related]

  • 3. Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800-mg oral dose.
    Hofbauer H, Naber KG, Kinzig-Schippers M, Sörgel F, Rustige-Wiedemann C, Wiedemann B, Reiz A, Kresken M.
    Infection; 1997 Oct; 25(2):121-6. PubMed ID: 9108190
    [Abstract] [Full Text] [Related]

  • 4. Urinary bactericidal activity and pharmacokinetics of enoxacin versus norfloxacin and ciprofloxacin in healthy volunteers after a single oral dose.
    Well M, Naber KG, Kinzig-Schippers M, Sörgel F.
    Int J Antimicrob Agents; 1998 Apr; 10(1):31-8. PubMed ID: 9624541
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin (400 mg) versus ciprofloxacin (500 mg) in healthy volunteers after a single oral dose.
    Boy D, Well M, Kinzig-Schippers M, Sörgel F, Ankel-Fuchs D, Naber KG.
    Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S6-16. PubMed ID: 15037323
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Urinary excretion and bactericidal activities of gemifloxacin and ofloxacin after a single oral dose in healthy volunteers.
    Naber CK, Hammer M, Kinzig-Schippers M, Sauber C, Sörgel F, Bygate EA, Fairless AJ, Machka K, Naber KG.
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3524-30. PubMed ID: 11709334
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bactericidal activity of ciprofloxacin, norfloxacin and ofloxacin in serum and urine after oral administration to healthy volunteers.
    Zeiler HJ, Beermann D, Wingender W, Förster D, Schacht P.
    Infection; 1988 Dec; 16 Suppl 1():S19-23. PubMed ID: 3286510
    [Abstract] [Full Text] [Related]

  • 13. Concentrations in plasma, urinary excretion, and bactericidal activity of linezolid (600 milligrams) versus those of ciprofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose.
    Wagenlehner FM, Wydra S, Onda H, Kinzig-Schippers M, Sörgel F, Naber KG.
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3789-94. PubMed ID: 14638484
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I, Cars O.
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Antibacterial activity of ciprofloxacin in the urine during four days after a single 500 mg and 750 mg oral dose].
    Guibert J, Kitzis MD, Acar JF.
    Pathol Biol (Paris); 1994 Jun; 42(6):587-92. PubMed ID: 7854859
    [Abstract] [Full Text] [Related]

  • 19. [In vitro short-term bactericidal activity and accumulation of NM394, the active metabolite of prulifloxacin, for Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa: comparison with ciprofloxacin, levofloxacin, and gatifloxacin].
    Shimizu M, Tabata M, Hara T, Araake M, Watabe H, Nishino T.
    Jpn J Antibiot; 2002 Dec; 55(6):791-9. PubMed ID: 12621733
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.